Recipharm AB, a leading contract development and manufacturing organisation (CDMO), is headquartered in Sweden (SE) and operates extensively across Europe, North America, and Asia. Founded in 1995, Recipharm has established itself as a key player in the pharmaceutical industry, specialising in the development and production of complex drug formulations, including sterile and non-sterile products.
The company offers a diverse range of services, from drug development and manufacturing to packaging and analytical services, catering to both small biotech firms and large pharmaceutical companies. Recipharm's commitment to quality and innovation has earned it a strong market position, with notable achievements in expanding its global footprint and enhancing its technological capabilities. With a focus on sustainability and efficiency, Recipharm continues to set benchmarks in the CDMO sector, making it a trusted partner for pharmaceutical companies worldwide.
+15 vs industry average
Recipharm’s score of 44 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Recipharm?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Research Services has typical carbon intensity
Industry performance
The Research Services industry has increased its overall emissions by 17% since 2019
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Recipharm's reported carbon emissions
In 2024, Recipharm reported total carbon emissions of approximately 207.99 million kg CO2e, comprising 22.77 million kg CO2e from Scope 1, 1.6 million kg CO2e from Scope 2, and 183.62 million kg CO2e from Scope 3 emissions. This data reflects a commitment to transparency in their environmental impact, with emissions data sourced directly from Recipharm AB (publ). Recipharm has set ambitious targets to reduce its carbon footprint. The company aims to achieve a 30% reduction in Scope 1 and Scope 2 emissions by 2025, using 2020 as a baseline. Furthermore, they have committed to reducing absolute Scope 1 and 2 GHG emissions by 42.1% by 2030 from a 2021 base year, a target validated by the Science Based Targets initiative (SBTi). Additionally, Recipharm plans to increase its sourcing of renewable electricity from 93.5% in 2021 to 100% by 2030. For Scope 3 emissions, Recipharm has pledged to reduce these by 25% by 2030, also from a 2021 baseline. This includes emissions from purchased goods and services, fuel and energy-related activities, and waste generated in operations, among others. The company is committed to achieving net-zero carbon emissions by 2050, demonstrating a long-term dedication to sustainability and climate action.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Recipharm’s Climate Goals (2030 & 2050)
4 goals2030
Net Zero Scope 2 GHG emissions by 2030
Net Zero Scope 2 GHG emissions by 2030
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 4 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Recipharm
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project